Associated Papers
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.
Ho GY et al.
Therapeutic Advances in Medical Oncology, 2023
38028140 (PubMed )
Supplement: sj-xlsx-2-tam-10.1177_17588359231208674.xlsx › Supp_Table_S2
Select a paper to view details